Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To assess the anti-inflammatory efficacy of rosiglitazone XR 8 mg administered once daily for a period of 6 months to subjects with rheumatoid arthritis who demonstrate active disease despite disease-modifying antirheumatic drug (DMARD) therapy.
Critère d'inclusion
- Rheumatoid Arthritis